Results for tag: "Fanconi Syndrome Drug"

The Fanconi Syndrome Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat Fanconi Syndrome, a rare genetic disorder that affects the kidneys and other organs. These drugs are used to reduce the symptoms of the disorder, such as excessive urination, dehydration, and electrolyte imbalances. They can also help to prevent further damage to the kidneys and other organs. The Fanconi Syndrome Drug market is a relatively small market, but it is growing as more people are diagnosed with the disorder. The drugs used to treat Fanconi Syndrome are typically expensive, and the cost of treatment can be a barrier to access for many patients. Some of the companies in the Fanconi Syndrome Drug market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are all involved in the development and marketing of drugs to treat Fanconi Syndrome. Show Less Read more